Aegerion Pharmaceuticals, Inc. (AEGR) Posts Q2 adj.-Loss of 6c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Aegerion Pharmaceuticals (AEGR) CEO Buys 10K Shares
July 31, 2014 12:45 PM EDTAegerion Pharmaceuticals (NASDAQ: AEGR) is off the lows of the session after CEO Marc Beer disclosed the purchae of 10,000 today at $33.37-$33.44.
Shares are down 5.5% after gaining 16% Wednesday following second quarter results.
... More